Table 3.
Current gaps recognizing in research and clinical practice of metastatic PPGLs
| Risk assessment models |
| Guidelines for care of metastatic PPGL |
| Surveillance programs for mutation carriers |
| Access to treatment opportunities |
| Genetic testing: not widely available |
| Opportunities for communication and discussion of care/surveillance of specific cases |